Commissural fusion as etiology of bioprosthetic mitral stenosis in a patient with rheumatic heart disease.
bioprosthesis
commissural fusion
early structural degeneration
rheumatic mitral stenosis
transcatheter valve replacement
valve-in-valve
Journal
Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
23
01
2020
revised:
20
02
2020
accepted:
01
03
2020
pubmed:
18
3
2020
medline:
24
6
2021
entrez:
18
3
2020
Statut:
ppublish
Résumé
We report commissural fusion as a unique morphologic etiology of early bioprosthetic mitral valve failure in a woman with a history of rheumatic mitral stenosis. She had undergone mitral valve replacement with a 25-mm Edwards Magna Ease bovine pericardial bioprosthesis 3 years earlier and presented with progressive dyspnea. Transesophageal echocardiography revealed severe bioprosthetic stenosis due to commissural fusion. She underwent percutaneous valve-in-valve implantation with a 26-mm Edwards Sapien 3 prosthesis. Marked symptomatic improvement was noted postprocedurally. We speculate that commissural fusion may be a unique pathologic feature of failing bioprosthetic valves in patients with prior rheumatic mitral valve disease.
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
637-640Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Côté N, Pibarot P, Clavel MA. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration. Curr Opin Cardiol. 2017;32:123-129.
Cremer PC, Rodriguez LL, Griffin BP, et al. Early bioprosthetic valve failure: mechanistic insights via correlation between echocardiographic and operative findings. J Am Soc Echocardiogr. 2015;28:1131-1148.
Dvir D, Bourguignon T, Otto CM, et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation. 2018;137:388-399.
Cullen MW, Cabalka AK, Alli OO, et al. Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. J Am Coll Cardiol Intv. 2013;6:598-605.
Wilbring M, Alexiou K, Tugtekin SM, et al. Transapical transcatheter valve-in-valve implantation for deteriorated mitral valve bioprostheses. Ann Thorac Surg. 2013;95:111-117.
Bouleti C, Fassa AA, Himbert D, et al. Trans-femoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty. J Am Coll Cardiol Intv. 2015;8:83-91.
Vainrib AF, Moses MJ, Benenstein RJ, et al. Multimodality imaging of bioprosthetic percutaneous balloon valvuloplasty followed by valve-in-valve implantation for mitral stenosis due to commissural leaflet fusion. JACC Cardiovasc Interv. 2016;9:e43-e45.
Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE. Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg. 2000;119:53-60.
Vohra HA, Whistance RN, Roubelakis A, et al. Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. Interact Cardiovasc Thorac Surg. 2012;14:575-579.
Potter DD, Sundt TM 3rd, Zehr KJ, et al. Risk of repeat mitral valve replacement for failed mitral valve prostheses. Ann Thorac Surg. 2004;78:67-72.
Eleid MF, Whisenant BK, Cabalka AK, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv. 2017;10:1932-1942.
Guerrero M, Dvir D, Himbert D, et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the First Multicenter Global Registry. JACC Cardiovasc Interv. 2016;9:1361-1371.
Hu J, Chen Y, Cheng S, et al. Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: a systematic review and meta-analysis. J Card Surg. 2018;33:508-519.
Shivaraju A, Michel J, Frangieh AH, et al. Transcatheter aortic and mitral valve-in-valve implantation using the Edwards Sapien 3 heart valve. J Am Heart Assoc. 2018;7:e007767.
Cheung A, Webb JG, Barbanti M, et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol. 2013;61:1759-1766.
Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732-738.
Tyers GF, Jamieson WR, Munro AI, et al. Reoperation in biological and mechanical valve populations: fate of the reoperative patient. Ann Thorac Surg. 1995;60(Suppl 2):S464-S468.
Dahm M, Lyman WD, Schwell AB, Factor SM, Frater RW. Immunogenicity of glutaraldehyde-tanned bovine pericardium. J Thorac Cardiovasc Surg. 1990;99:1082-1090.
Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol. 1986;123:134-145.
Shetty R, Pibarot P, Audet A, et al. Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. Eur J Clin Invest. 2009;39:471-480.